New pill aims to stop Weight-Loss drug side effects
NCT ID NCT06804603
Summary
This study tested if a drug called tradipitant could reduce the common side effects of nausea and vomiting caused by GLP-1 agonist medications, which are used for weight loss. It involved 124 healthy, overweight volunteers who took either tradipitant or a placebo (a dummy pill) alongside the weight-loss medication. The main goal was to see if tradipitant helped people experience fewer vomiting episodes and less severe nausea.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanda Investigational Site
Los Angeles, California, 90025, United States
-
Vanda Investigational Site
Rochester, Minnesota, 55905, United States
-
Vanda Investigational Site
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.